Filing search / Baudax Bio, Inc. / "Executive Compensation"

424B5

BXRXQ Baudax Bio, Inc.

18 Aug 23

Prospectus supplement for primary offering

4:40pm

with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation … to approve executive compensation and shareholder approval of any golden parachute payments not previously approved. We will take advantage

424B3

2z7t35n

28 Apr 23

Prospectus supplement

4:02pm

424B3

y3yrw

5 Dec 22

Prospectus supplement

4:37pm

424B4

tczzj1

31 Aug 22

Prospectus supplement with pricing info

4:08pm

S-1

15re1yxd

3 Aug 22

IPO registration

5:17pm

424B5

ftegwlfx2 hux62nt2

19 May 22

Prospectus supplement for primary offering

6:07am